Earnings Per Share, Basic in USD/shares of PLUS THERAPEUTICS, INC. from Q2 2014 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
PLUS THERAPEUTICS, INC. quarterly/annual Earnings Per Share, Basic history and change rate from Q2 2014 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.04 USD/shares, a 89.2% increase year-over-year.
  • PLUS THERAPEUTICS, INC. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was -1 USD/shares, a 26% increase year-over-year.
  • PLUS THERAPEUTICS, INC. annual Earnings Per Share, Basic for 2024 was -1.95 USD/shares, a 54% increase from 2023.
  • PLUS THERAPEUTICS, INC. annual Earnings Per Share, Basic for 2023 was -4.24 USD/shares, a 63.4% increase from 2022.
  • PLUS THERAPEUTICS, INC. annual Earnings Per Share, Basic for 2022 was -11.6 USD/shares, a 943% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

PLUS THERAPEUTICS, INC. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$1 $0 +$0.33 +89.2% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$1 $0.02 +$0.47 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$2 -$1 $0 -58.7% 01 Jan 2025 31 Mar 2025 10-Q 30 May 2025
Q4 2024 -$1 $0 +$0.20 +34.5% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$2 $0 +$0.63 +63% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 -$2 $0 +$0.14 +23.7% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$2 -$1 +$1.32 +63.8% 01 Jan 2024 31 Mar 2024 10-Q 30 May 2025
Q4 2023 -$4 -$1 +$4.40 +88.4% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$8 -$1 +$1.85 +64.9% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$10 -$1 +$2.97 +83.4% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$13 -$2 -$2 -989% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$11 -$5 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 -$3 -$3 -918% 01 Jul 2022 30 Sep 2022 10-Q 31 Oct 2023
Q2 2022 -$4 -$3 -1324% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $0 01 Jan 2022 31 Mar 2022 10-Q 20 Apr 2023
Q3 2021 $0 01 Jul 2021 30 Sep 2021 10-Q 20 Oct 2022
Q2 2021 $0 01 Apr 2021 30 Jun 2021 10-Q 21 Jul 2022
Q3 2016 $0 $0 -273% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $0 -$1 -190% 01 Apr 2016 30 Jun 2016 10-Q 05 Aug 2016
Q3 2015 $0.15 +$0.27 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $0.48 +$0.63 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q3 2014 $0 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 $0 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015

PLUS THERAPEUTICS, INC. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$2 +$2.29 +54% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$4 +$7.34 +63.4% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$12 -$11 -943% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 -$1 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.